ID: MRFR/PNT/3741-CR | 172 Pages | Author: Pradeep Nandi | August 2021
The pharmaceutical glass packaging market size was valued at USD 4379.5 million in 2021. The pharmaceutical glass packaging industry is projected to grow from USD 4751.76 million in 2022 to USD 8411.29 million by 2030, exhibiting a compound annual growth rate (CAGR) of 8.50% during the forecast period (2022 - 2030). The growing pharmaceutical industry and inclination towards glass medicines owing to their beneficial features are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Future market expansion for pharmaceutical glass packaging is anticipated to be driven by the growth of the pharmaceutical sector. The research, development, and production of medicines and treatments are part of the pharmaceutical sector. Strong acids, alkalis, and pharmaceutical glass packaging are utilized for packaging and storing these substances. For instance, the Indian pharmaceutical market expanded by 17.7% yearly in 2021, up from 13.7% in July 2020, according to the Indian Brand Equity Foundation, an Indian government organization, and the market revenue is anticipated to be over 12% in 2022. As a result, the pharmaceutical glass packaging market is expanding as the pharmaceutical sector expands.
Technological advancements are the primary trend gaining traction in the pharmaceutical glass packaging market. To strengthen their position in the market, major pharmaceutical logistics companies are developing new technology. For instance, the Gx Elite vials, which are produced utilizing cutting-edge technology, Gx RHOC systems, were introduced by Gerresheimer, a German maker of pharmaceutical glass packaging and glass injections for patients, in January 2020. This is a brand-new type I borosilicate glass container called a G.X. Elite vial. These glass tubes are top-quality tubular vials. Customers and patients can buy this product with confidence. Therefore, such factors have recently enhanced the market CAGR across the globe in the recent years.
In May 2021, Piramida was purchased by Nipro, a Japanese business that deals in glass packaging for pharmaceuticals. The acquisition is anticipated to improve Nipro's production capacity. also contributes to the ampoules and vials business of Nipro. Glass vials and ampoules of the highest quality are produced by the Latvian company Piramida for use in medicinal products. This will be In May 2021, Piramida was purchased by Nipro, a Japanese business that deals in glass packaging for pharmaceuticals. The acquisition is anticipated to improve Nipro's production capacity. It also contributes to the ampoules and vials business of Nipro. Glass vials and ampoules of the highest quality are produced by the Latvian company Piramida for use in medicinal products. This will expand the pharmaceutical glass packaging industry to expand and act as another factor driving the growth of the pharmaceutical glass packaging market revenue.
The pharmaceutical glass packaging market segmentation, based on product, includes vials, bottles & jars, cartridges & syringes, and ampoules. The vials pharmaceutical glass packaging segment held the majority share in 2021 contribution to around ~55-60% in respect to the pharmaceutical glass packaging market revenue.Glass vials are constructed with Type 1 borosilicate glass gives them the appropriate level of chemical resistance. Vials are projected to be the segment with the quickest growth rate due to their high analytical performance and excellent sustainability.
August 2021: Serum Institute of India (SII) buys a 50% stake in SCHOTT Kaisha in order to join SCHOTT in a joint venture and guarantee a supply of pharmaceutical packaging. The joint venture is the top producer of pharmaceutical packaging items in India, including vials, syringes, ampoules, and cartridges used to package life-saving drugs.
Due to glass's capacity to filter particular wavelengths, its high level of microbiological control, and its superior chemical resistance, the ampoules pharmaceutical glass packaging market that is made primarily of glass is predicted to expand with the most alluring CAGR in terms of revenue during the projection period. Ampoules with sealed, funnel-style, and straight-stem designs are produced in large quantities under DIN ISO EN 9187-1/2 standard.
The pharmaceutical glass packaging market segmentation, based on the application, includes generic drugs, branded drugs, and biological drugs. The market was led by generic drug types of pharmaceutical glass packaging in 2021, accounting for the highest proportion of worldwide revenue. Due to an aging population, an increase in chronic disease cases, and a growth in drug patents that have expired in recent years, the market for generic medications has grown. Additional reasons that are projected to increase the use of generic pharmaceuticals include government and healthcare provider attempts to lower healthcare costs and drug prices, as well as the availability of health insurance. Due to its regulatory simplicity and exceptional barrier properties, the rising use of generic medications is anticipated to enhance demand for pharmaceutical glass packaging. Hence, the rising adoption of generic drug applications positively impacts market growth.
The growth of biologic pharmaceutical glass packaging is mostly attributed to their effectiveness in treating serious chronic diseases, particularly specific types of autoimmune diseases and cancer. The rise of biologic drugs and pharmaceutical glass packaging is expected to be restrained by glass delamination and chipping caused by surface deterioration. Owing to the factors mentioned, biologic drugs is the second fastest-growing segment in the pharmaceutical glass packaging market.
By region, the study provides the market insights North America, Europe, Asia-Pacific, and the Rest of the World. Asia Pacific market accounted for USD 2005.811 million in 2021 and is anticipated to exhibit a CAGR of 45.80% growth during the study period. Regarding revenue, Asia Pacific is expected to be the largest region. Numerous small and medium-sized industrial facilities in the area are evidence of this increase in demand. Additionally, the region benefits from a lax regulatory environment that helps manufacturers and draws in outside investment. Companies like Corning and Schott AG frequently collaborate with small-scale production facilities in the area to extend their regional presence and increase their market share.
Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
North America pharmaceutical glass packaging market. In the approaching years, the pharmaceutical industry's spending is anticipated to soar in developing markets. With innovative goods driving the growth, the U.S. pharmaceutical glass packaging market is anticipated to remain a significant region and driver for the expansion of the pharmaceutical industry in the area. The increase in generic drugs in the area, which is likely to result in consistently high demand in terms of volume and sales, is anticipated to contribute to this expansion.
The Europe pharmaceutical glass packaging market is anticipated to expand at the fastest CAGR from 2022 to 2030. A major strength of the European economy is the pharmaceutical industry, which is built on research. Due to the expansion of medical research, development, and the launch of new medications aimed at enhancing the health and quality of life of patients in the area, the pharmaceutical glass packaging sector is on the increase. Moreover, Germany pharmaceutical glass packaging market held the largest market share, and the UK pharmaceutical glass packaging market was the fastest growing market in the Europe region
For instance, Germany pharmaceutical glass packaging market is growing. The Federal Association of the German Glass Sector estimates that the country's top 10 glass makers bring in about 20% of the total revenue for the glass industry. The market is currently dominated by a select group of large international glassmakers who are interested in making glass bottles. Hence, Europe is anticipated to register the highest growth rate over the forecast period from 2022–2030.
Major market players are investing a lot of time and capital and other financial investments like R&D to improve their product portfolios, which will help the market grow faster. Market participants are also taking a range of both growth initiatives to extend their international reach, with key market developments such as product innovations & new product developments, contractual agreements, mergers & acquisitions, increased investments, and strategic collaboration with other organizations. Competitors in the pharmaceutical glass packaging industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the pharmaceutical glass packaging industry to help clients and expand the market sector is to produce locally to decrease operating expenses. In recent years, pharmaceutical glass packaging industry has provided industries with some of the most significant benefits. The market major player such as Schott AG (Germany), Nipro Corporation (Japan), Piramal Glass (Mumbai), Sisecam Group, Owens-Illinois Inc.(US), and others are working to scale the market demand by investing aggressively in research and development initiatives across pharmaceutical glass packaging.
Nipro Corporation (Japan) is a leading supplier of glass primary packaging for the pharmaceutical sector. Pre-fillable syringes, vials, cartridges, and ampoules are the Japanese-quality items the company creates and manufactures. In May 2021, The maker of glass pharmaceutical packaging in Croatia, Piramida, was purchased by Nipro Corporation, a Japanese packaging company. With the purchase of Piramida and its annual capacity of more than 500 million glass containers, Nipro is now equipped to meet the market's demands in Central Europe.
Schott AG (Germany)
Nipro Corporation (Japan)
Piramal Glass (Mumbai)
Sisecam Group
Owens-Illinois Inc.(US)
Gerresheimer AG (Germany)
SGD Pharma (France)
Bormioli Pharma S.p.A (Italy)
Ardagh Group S.A.(Luxembourg)
West Pharmaceutical Services Inc.(US), among others
April 2022: In their Schleusingen, Germany, factory, Wiegand-Glas started a new furnace. Despite the extremely volatile supply and pricing situations on the energy market, Wiegand-Glas management chose to start the second furnace at the new glass facility in Thuringia.
May 2023: Schott AG announced the launch of its new range of pharmaceutical glass vials for injectables. The vials are made from borosilicate glass and are designed to provide high levels of protection for injectable drugs.
Vials
Bottles & Jars
Cartridges & Syringes
Ampoules
Generic Drugs
Branded Drugs
Biological Drugs
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
Report Attribute/Metric | Details |
Market Size 2021 | USD 4379.5 million |
Market Size 2022 | USD 4751.76 million |
Market Size 2030 | USD 8411.29 million |
Compound Annual Growth Rate (CAGR) | 8.50 % (2022-2030) |
Base Year | 2021 |
Market Forecast Period | 2022-2030 |
Historical Data | 2018 & 2020 |
Market Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product, Application, and Region |
Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled | Schott AG (Germany), Nipro Corporation (Japan), Piramal Glass(Mumbai), Sisecam Group, Owens-Illinois Inc.(US), Gerresheimer AG (Germany), SGD Pharma (France), Bormioli Pharma S.p.A (Italy), Ardagh Group S.A.(Luxembourg), and West Pharmaceutical Services Inc.(US) |
Key Market Opportunities | Increasing technological developments |
Key Market Dynamics | Growing Pharmaceutical Industry Rising demand for packaging |
The pharmaceutical glass packaging market size was valued at USD 4379.5 million in 2021.
The pharmaceutical glass packaging market is projected to grow at a CAGR of 8.50% during the forecast period, 2022-2030.
Asia Pacific had the largest share in the Pharmaceutical Glass Packaging market
The key players in the market are Schott AG (Germany), Nipro Corporation (Japan), Piramal Glass (Mumbai), Sisecam Group, Owens-Illinois Inc.(US).
The vials pharmaceutical glass packaging category dominated the pharmaceutical glass packaging market in 2021.
The generic drugs had the largest share in the pharmaceutical glass packaging market market.
Key Questions Answered
Why Choose Market Research Future?